[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sustained Release Ocular Drug Delivery Systems Industry Research Report 2020, Forecast to 2025

May 2020 | 102 pages | ID: G4B9485A395EEN
WKinformation

US$ 2,560.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The Sustained Release Ocular Drug Delivery Systems market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Sustained Release Ocular Drug Delivery Systems is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Sustained Release Ocular Drug Delivery Systems industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Sustained Release Ocular Drug Delivery Systems by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Sustained Release Ocular Drug Delivery Systems market are discussed.

The market is segmented by types:
  • Liposome
  • Microcapsules/Nanocapsules
  • Microspheres/Nanosptheres
  • Implants
It can be also divided by applications:
  • Cataract
  • Glaucoma
  • Corneal Transplantation
  • Others
And this report covers the historical situation, present status and the future prospects of the global Sustained Release Ocular Drug Delivery Systems market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
  • pSivida
  • Envisia Therapeutics
  • Ocular Therapeutix
  • Allergan
  • Aciont Inc.
  • Icon Bioscience
  • Innocore Pharmaceuticals
  • Santen Pharmaceutical
  • Neurotech Pharmaceuticals
  • GrayBug
  • OHR Pharmaceuticals
  • PolyActiva
  • TheraKine
Report Includes:
  • xx data tables and xx additional tables
  • An overview of global Sustained Release Ocular Drug Delivery Systems market
  • An detailed key players analysis across regions
  • Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Insights into regulatory and environmental developments
  • Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Sustained Release Ocular Drug Delivery Systems market
  • Profiles of major players in the industry, including - pSivida, Envisia Therapeutics, Ocular Therapeutix, Allergan, Aciont Inc......
Research objectives
  • To study and analyze the global Sustained Release Ocular Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Sustained Release Ocular Drug Delivery Systems market by identifying its various subsegments.
  • Focuses on the key global Sustained Release Ocular Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
  • To analyze the Sustained Release Ocular Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Sustained Release Ocular Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
Global Sustained Release Ocular Drug Delivery Systems Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Sustained Release Ocular Drug Delivery Systems Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS INDUSTRY OVERVIEW

2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Sustained Release Ocular Drug Delivery Systems Global Import Market Analysis
  2.1.2 Sustained Release Ocular Drug Delivery Systems Global Export Market Analysis
  2.1.3 Sustained Release Ocular Drug Delivery Systems Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Liposome
  2.2.2 Microcapsules/Nanocapsules
  2.2.3 Microspheres/Nanosptheres
  2.2.4 Implants
2.3 Market Analysis by Application
  2.3.1 Cataract
  2.3.2 Glaucoma
  2.3.3 Corneal Transplantation
  2.3.4 Others
2.4 Global Sustained Release Ocular Drug Delivery Systems Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Sustained Release Ocular Drug Delivery Systems Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share
  2.4.5 Top 10 Sustained Release Ocular Drug Delivery Systems Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
  2.4.7 Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Sustained Release Ocular Drug Delivery Systems Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Sustained Release Ocular Drug Delivery Systems Industry Impact
  2.7.1 How the Covid-19 is Affecting the Sustained Release Ocular Drug Delivery Systems Industry
  2.7.2 Sustained Release Ocular Drug Delivery Systems Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Sustained Release Ocular Drug Delivery Systems Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2019)
4.3 Global Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Sustained Release Ocular Drug Delivery Systems Market Size Detail
  4.4.1 North America Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020)
  4.4.2 North America Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Sustained Release Ocular Drug Delivery Systems Market Size Detail
  4.5.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020)
  4.5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Sustained Release Ocular Drug Delivery Systems Market Size Detail
  4.6.1 Japan Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020)
  4.6.2 Japan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Sustained Release Ocular Drug Delivery Systems Market Size Detail
  4.7.1 China Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2015-2020)
  4.7.2 China Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET SEGMENT BY TYPE

5.1 Global Sustained Release Ocular Drug Delivery Systems Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type (2015-2020)
  5.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2015-2020)
5.2 Liposome Sales Growth Rate and Price
  5.2.1 Global Liposome Sales Growth Rate (2015-2020)
  5.2.2 Global Liposome Price (2015-2020)
5.3 Microcapsules/Nanocapsules Sales Growth Rate and Price
  5.3.1 Global Microcapsules/Nanocapsules Sales Growth Rate (2015-2020)
  5.3.2 Global Microcapsules/Nanocapsules Price (2015-2020)
5.4 Microspheres/Nanosptheres Sales Growth Rate and Price
  5.4.1 Global Microspheres/Nanosptheres Sales Growth Rate (2015-2020)
  5.4.2 Global Microspheres/Nanosptheres Price (2015-2020)
5.5 Implants Sales Growth Rate and Price
  5.5.1 Global Implants Sales Growth Rate (2015-2020)
  5.5.2 Global Implants Price (2015-2020)

6 GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET SEGMENT BY APPLICATION

6.1 Global Sustained Release Ocular Drug Delivery SystemsSales Market Share by Application (2015-2020)
6.2 Cataract Sales Growth Rate (2015-2020)
6.3 Glaucoma Sales Growth Rate (2015-2020)
6.4 Corneal Transplantation Sales Growth Rate (2015-2020)
6.5 Others Sales Growth Rate (2015-2020)

7 GLOBAL SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET FORECAST

7.1 Global Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast
  7.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2020-2025)
7.2 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2020-2025)
  7.2.1 North America Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Sustained Release Ocular Drug Delivery Systems Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Sustained Release Ocular Drug Delivery Systems Production, Revenue Forecast (2020-2025)
  7.2.4 China Sustained Release Ocular Drug Delivery Systems Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS INDUSTRY KEY MANUFACTURERS

8.1 pSivida
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 pSivida News
8.2 Envisia Therapeutics
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Envisia Therapeutics News
8.3 Ocular Therapeutix
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Ocular Therapeutix News
8.4 Allergan
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Allergan Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Allergan News
8.5 Aciont Inc.
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Aciont Inc. News
8.6 Icon Bioscience
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Icon Bioscience News
8.7 Innocore Pharmaceuticals
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Innocore Pharmaceuticals News
8.8 Santen Pharmaceutical
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Santen Pharmaceutical News
8.9 Neurotech Pharmaceuticals
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Neurotech Pharmaceuticals News
8.10 GrayBug
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 GrayBug Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 GrayBug News
8.11 OHR Pharmaceuticals
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 OHR Pharmaceuticals News
8.12 PolyActiva
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 PolyActiva News
8.13 TheraKine
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 TheraKine News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX
LIST OF TABLES AND FIGURES

Figure Sustained Release Ocular Drug Delivery Systems Picture
Figure Research Programs/Design for This Report
Figure Global Sustained Release Ocular Drug Delivery Systems Market by Regions (2019)
Table Global Market Sustained Release Ocular Drug Delivery Systems Comparison by Regions (M USD) 2019-2025
Table Global Sustained Release Ocular Drug Delivery Systems Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type in 2019
Figure Liposome Picture
Figure Microcapsules/Nanocapsules Picture
Figure Microspheres/Nanosptheres Picture
Figure Implants Picture
Table Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2019-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure Cataract Picture
Figure Glaucoma Picture
Figure Corneal Transplantation Picture
Figure Others Picture
Table Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer (2018-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturer in 2019
Table Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2018-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturer in 2019
Table Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Sustained Release Ocular Drug Delivery Systems Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table Key Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units) by Region (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2019)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2015-2019)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2018
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Region (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2019
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020)
Table North America Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020)
Table Japan Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate (2015-2020)
Table China Sustained Release Ocular Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2019
Table Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type in 2019
Figure Global Liposome Sales Growth Rate (2015-2020)
Figure Global Liposome Price (2015-2020)
Figure Global Microcapsules/Nanocapsules Sales Growth Rate (2015-2020)
Figure Global Microcapsules/Nanocapsules Price (2015-2020)
Figure Global Microspheres/Nanosptheres Sales Growth Rate (2015-2020)
Figure Global Microspheres/Nanosptheres Price (2015-2020)
Figure Global Implants Sales Growth Rate (2015-2020)
Figure Global Implants Price (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2015-2020)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2019
Figure Global Cataract Sales Growth Rate (2015-2020)
Figure Global Glaucoma Sales Growth Rate (2015-2020)
Figure Global Corneal Transplantation Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2020-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Units) Forecast by Region (2020-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Production Market Share Forecast by Region (2020-2025)
Figure North America Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Sustained Release Ocular Drug Delivery Systems Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table pSivida Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of pSivida
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure pSivida Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table pSivida Main Business
Table pSivida Recent Development
Table Envisia Therapeutics Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Envisia Therapeutics
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Envisia Therapeutics Main Business
Table Envisia Therapeutics Recent Development
Table Ocular Therapeutix Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Ocular Therapeutix
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Ocular Therapeutix Main Business
Table Ocular Therapeutix Recent Development
Table Allergan Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Allergan
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Allergan Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Allergan Main Business
Table Allergan Recent Development
Table Aciont Inc. Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Aciont Inc.
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Aciont Inc. Main Business
Table Aciont Inc. Recent Development
Table Icon Bioscience Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Icon Bioscience
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Icon Bioscience Main Business
Table Icon Bioscience Recent Development
Table Innocore Pharmaceuticals Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Innocore Pharmaceuticals
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Innocore Pharmaceuticals Main Business
Table Innocore Pharmaceuticals Recent Development
Table Santen Pharmaceutical Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Santen Pharmaceutical
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Santen Pharmaceutical Main Business
Table Santen Pharmaceutical Recent Development
Table Neurotech Pharmaceuticals Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of Neurotech Pharmaceuticals
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table Neurotech Pharmaceuticals Main Business
Table Neurotech Pharmaceuticals Recent Development
Table GrayBug Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of GrayBug
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table GrayBug Main Business
Table GrayBug Recent Development
Table OHR Pharmaceuticals Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of OHR Pharmaceuticals
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table OHR Pharmaceuticals Main Business
Table OHR Pharmaceuticals Recent Development
Table PolyActiva Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of PolyActiva
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure PolyActiva Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table PolyActiva Main Business
Table PolyActiva Recent Development
Table TheraKine Company Profile
Figure Sustained Release Ocular Drug Delivery Systems Product Picture and Specifications of TheraKine
Table Sustained Release Ocular Drug Delivery Systems Production, Price, Revenue and Gross Margin of 2018-2020
Figure TheraKine Sustained Release Ocular Drug Delivery Systems Market Share (2018-2020)
Table TheraKine Main Business
Table TheraKine Recent Development
Table of Appendix


More Publications